Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hübschmann

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
Nature Methods|August 7, 2025
Ultra-high-scale cytometry-based cellular interaction mappingDominik Vonficht, Lea Jopp-Saile, Schayan Yousefian, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Molecular Oncology|May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancersMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
Blood|October 5, 2018
IG-<i>MYC</i> <sup>+</sup> neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasRabea Wagener, Cristina López, Kortine Kleinheinz, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Nature Communications|November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapyRaphael Lutz, Florian Grünschläger, Malte Simon, et al.
Journal of Inherited Metabolic Disease|July 15, 2023
Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolismYılmaz Yıldız, Oya Kuseyri Hübschmann, Ayça Akgöz Karaosmanoğlu, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
Nature Methods|August 7, 2025
Ultra-high-scale cytometry-based cellular interaction mappingDominik Vonficht, Lea Jopp-Saile, Schayan Yousefian, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Molecular Oncology|May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancersMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
Blood|October 5, 2018
IG-<i>MYC</i> <sup>+</sup> neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasRabea Wagener, Cristina López, Kortine Kleinheinz, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Nature Communications|November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapyRaphael Lutz, Florian Grünschläger, Malte Simon, et al.
Journal of Inherited Metabolic Disease|July 15, 2023
Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolismYılmaz Yıldız, Oya Kuseyri Hübschmann, Ayça Akgöz Karaosmanoğlu, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Pageof 10